Alt image -https://content.stockstotrade.com/wp-content/uploads/2026/07/skin-stock-pops-on-volume-as-balance-sheet-draws-focus.jpg
https://stockstotrade-nuxt-staging.stockstotrade-com-inc.workers.dev/

SKIN Stock Pops On Volume As Balance Sheet Draws Focus

TIM BOHENUPDATED JUL. 7, 2026, 10:04 AM ET
Reviewed by Ben Sturgilland Fact-checked by Ellis Hobbs

SkinHealth Systems Inc. surged as stocks have been trading up by 36.3 percent after transformative dermatology breakthrough reports.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading SKIN

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways

  • SKIN shares jumped from sub-$0.80 to above $1.00 on heavy trading, signaling fresh speculative momentum.
  • The daily chart shows a short-term uptrend, with SKIN closing higher in five of the last seven sessions.
  • SkinHealth Systems Inc. carries $260.0M in long-term debt but also sits on roughly $199.4M in cash, giving traders a defined risk backdrop.
  • SKIN is still posting quarterly losses, yet its 64.9% gross margin and positive EBITDA hint at an underlying core business.

Candlestick Chart

Live Update At 10:04:20 EDT: On Tuesday, July 07, 2026 SkinHealth Systems Inc. stock [NASDAQ: SKIN] is trending up by 36.3%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

SkinHealth Systems Inc., trading under ticker SKIN, is a classic small-cap turnaround setup that traders love to stalk. Revenue for the latest quarter came in near $64.9M, and the company booked about $44.4M in gross profit, which works out to a strong 64.9% gross margin. That tells traders SKIN can still make solid money on each dollar of sales.

The problem shows up lower on the income statement. SKIN reported a net loss of about $6.6M for the quarter, or roughly -$0.05 per share. Heavy selling and marketing spend around $23.2M and G&A at $21.9M keep the company in the red. EBITDA is slightly positive at roughly $5.9M, but interest expense of about $6.3M and high leverage weigh on the bottom line.

More Breaking News

On the balance sheet, SKIN shows around $473.2M in total assets and $418.0M in liabilities, including $260.0M in long-term debt and about $103.0M in current debt. There is roughly $199.4M of cash and restricted cash, which buys time. For traders, SKIN is a leveraged, margin-rich business trying to claw its way to sustainable profitability.

Why Traders Are Watching SKIN Price Action

The chart is where SKIN really gets the trading crowd’s attention. Over the past couple of weeks, SkinHealth Systems Inc. has quietly shifted from grinding in the mid-$0.60s to ripping above $1.00. On 2026/07/07, SKIN opened at $0.77 and ripped as high as $1.09, closing around $1.03. That’s a massive intraday range and exactly the kind of volatility active traders hunt.

Zoom into the 5-minute chart and you see textbook momentum. SKIN opened at $0.77 at the bell, quickly pushed into the $0.88–$0.96 zone, then extended into a $1.05–$1.09 spike before cooling back near $1.03. That pattern — strong open, push, consolidation above VWAP-type levels — screams momentum day trade. Each pullback found buyers stepping in higher than the last, a sign that shorts were getting squeezed and late longs were chasing.

On the daily chart, the move looks like a clean trend shift. SKIN closed at $0.65–$0.70 for days, then started printing higher lows: $0.66, $0.69, $0.71, $0.72, then a push to $0.75 and finally $1.03. Traders watching SkinHealth Systems Inc. are now treating the $0.70–$0.75 zone as key support, with $1.10+ as the first real breakout area.

Because SKIN trades under $5 and now has proven it can move 30–40% in a day, it fits right into the small-cap momentum playbook. The combination of leverage, high gross margins, and clear volatility makes SKIN a stock that short-term traders can plan around — with tight risk, defined levels, and no need to marry the story.

Conclusion

For active traders, SKIN sits at the crossroads of hype and hard numbers. The hard numbers say SkinHealth Systems Inc. is still losing money, burning about $5.6M in operating cash in the latest quarter and carrying a heavy $260.0M long-term debt load. Interest coverage around 2x and a leverage ratio of 8.6 scream “highly geared.” That’s risk.

But those same numbers also show why traders keep circling SKIN. The company has nearly $199.4M in cash, positive EBITDA, and a 64.9% gross margin. Revenue is in the $65M-per-quarter range, and asset turnover sits near 0.5. This is not a shell; it is a real operating business trying to fix its capital structure and cost base.

On the tape, SKIN just proved it can move. A push from the $0.60s into the $1.00+ zone in a handful of sessions, plus a big intraday spike, is enough to put SkinHealth Systems Inc. on every momentum scanner. Now traders will watch whether SKIN can hold above prior resistance in the mid-$0.70s and build a base. This is where consistent screen time and disciplined preparation matter most. As Tim Bohen, lead trainer with StocksToTrade says, “A consistent trading routine beats sporadic action every time. Show up daily, and you’ll start to see the patterns others miss.” For traders tracking SKIN, that routine can be the difference between randomly chasing spikes and recognizing a high-probability setup as it develops.

As Tim Sykes likes to tell students, “Patterns repeat because human nature never changes.” SKIN is now a live pattern. Traders who study the chart, respect the leverage, and cut losses fast will be the ones ready if SkinHealth Systems Inc. sets up for the next leg. This is educational, not a signal — but SKIN’s price action is a real-time classroom.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.


The Game is Rigged

But Our AI-driven analysis Has Leveled the Playing Field

Sign up for access to institutional grade tools and insights – and join 10,000+ traders